Strategic initiative creates integrated platform dedicated to next generation precision medicine
Healthcare Global Enterprises announced the execution of definitive agreements for the business combination of its Triesta Sciences business unit (Triesta) with Strand Life Sciences (Strand).Strand, established in 2000 as a spin-off from the Indian Institute of Science, is a bioinformatics company working with global technology vendors and research laboratories, and is the leader in genomic testing for cancer and inherited diseases in India. Triesta, a unit of HCG, offers comprehensive molecular diagnostics services and research services in the field of oncology.
The combination of Triesta and Strand creates an integrated platform with end to end capabilities in precision medicine - proprietary analytics, clinical research, access to the HCG biorepository, genomic technologies, assay development and validation and a network of laboratories offering a broad menu of tests.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
